The Cancer

Don't Miss

How Caregivers Can Assist Liked Ones With Lung Most cancers Really feel in Management

Chris Draft mentioned sufferers with lung most cancers and their caregivers can regain management after analysis by displaying up, staying knowledgeable and leaning into advocacy,...

Household Begins AYA Most cancers Basis After Lymphoma Prognosis

Elaine Riozzi Bodine and her daughter Alayna turned a life-altering analysis right into a mission to help different adolescents and younger adults with most cancers....

Childhood Most cancers Survivors Face Lengthy-Time period Meningioma Danger

Researchers at UT Southwestern Medical Heart led a research revealed in JAMA Community Open which discovered that particular chemotherapies are related to an elevated long-term...

Vital Information

Facts

Latest Articles

Odronextamab Elicits Responses in Some With Lymphoma Following CAR-T

Amongst some sufferers with relapsed/refractory diffuse massive B-cell lymphoma whose illness progressed after CAR-T cell remedy, remedy with the bispecific antibody odronextamab has...

Advocacy and ‘Radiating Valor’ Have a Transformative Affect

From left: MATTHEW MANGOLD, B.S.N., RN, and ERIN LONGSTRETH, M.S.N., RN, OCN, NEA-BCI'm privileged to appoint Matthew Mangold, B.S.N., RN, for the Extraordinary...

Air Issues: Radon and the Atmosphere

On January 15, people gathered for the Air Issues: Radon & The Atmosphere Group Schooling Occasion.On January 15, group members, well being professionals,...

Remission is Not a Treatment for Follicular Lymphoma, or Any Most cancers

Karen Cohn is a retired center faculty particular training instructor who was recognized with follicular lymphoma in July 2020. Make amends for all...

First Affected person with CD5-Constructive T-Cell Lymphoma Dosed with MB-105

The primary affected person with relapsed or refractory CD5-positive T-cell lymphoma has been dosed with the CAR-T cell remedy MB-105 in a part...

Hot Topics